CTI BioPharma Transaction Call

Recent Posts

DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the U.S. Sales of Veligrotug and VRDN-0...

DRI Healthcare to Host Third Quarter 2025 Earnings Call and Webcast on November 6, 2025

DRI Healthcare Trust Promotes Zaheed Mawani to Chief Financial Officer